SYNSIGHT Information

View Top Employees from SYNSIGHT

Synsight was a company created in 2013, by two co-founders PhD Computer aided drug design: Cyril Bauvais (CEO) and Guillaume Bollot (CSO). In july 2024, Synsight was acquired by @iktos, an AI drug discovery company. Its tech is based on AI drug design and cell imaging, including a proprietary cell based assay named MTBench, to profile compounds modulators of protein-protein and protein-RNA interactions, and protein agregation.

Website	https://iktos.ai/
Revenue	$19.9 million
Employees	3 (0 on RocketReach)
Founded	2013
Address	4 Rue Pierre Fontaine, Evry, Ile-de-France 91058, FR
Phone	+33 1 69 47 01 76
Technologies	JavaScript , HTML , PHP +12 more (view full list)
Industry	Pharmaceutical Manufacturing, Business Services General, Biopharma, Business Services, Biotechnology, Health Care, Science and Engineering, Genetics, Life Science
Keywords	Ai Drug Discovery, Drug Design, Cell Imaging, Drug Development, Drug Target Identification, Biotechnology, Proteomics, Computational Biology, Pharmaceutical, Bioinformatics, Machine Learning, High Throughput Screening, Molecular Modeling, Artificial Intelligence, Precision Medicine, Deep Learning
Competitors	Johnson & Johnson, Roche, Novartis, AbbVie, Merck & Co., Inc., Pfizer, Sanofi, GSK, Bristol Myers Squibb, Amgen +45 more (view full list)
SIC	SIC Code 873 Companies, SIC Code 87 Companies
NAICS	NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 541713 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies